“Tübingen University is the first major German University adopting echotherapy to treat breast fibroadenoma”, says José Abellan, VP Central Europe. “The University is an important reference center and will help drive clinical adoption of this innovative treatment technique that is scarless and delivered under simple local anaesthesia.”
David Caumartin, CEO Theraclion, says: “The published results confirm the safety and the efficacy of Theraclion’s echotherapy solution. We also welcome the fact that the University has decided to continue our collaboration beyond the initial purely academic scope. Tübingen is a strategic partner for us in Germany and we appreciate, with Professor Hahn, the engagement of one of the most renowned breast surgeons in Germany.”
Ad Statistics
Times Displayed: 113248
Times Visited: 6741 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About Theraclion
Theraclion is a French company specializing in high-tech medical equipment using therapeutic ultrasound. Drawing on leading-edge technologies, Theraclion has designed and manufactured an innovative solution for echotherapy, the Echopulse®, allowing non-invasive tumor treatment through ultrasound-guided high-intensity focused ultrasound. Theraclion is ISO 13485 certified and has received the CE mark for non-invasive ablation of breast fibroadenomas and thyroid nodules. Based in Malakoff, near Paris, France Theraclion has brought together a team of 34 people, 50% of whom are dedicated to R&D and clinical trials. For more information, please visit Theraclion’s website: www.theraclion.com.
Back to HCB News
